At the news
? NEUTRALIMPACT 2/10 8-K filed Oct 1, 2026 at 08:20 ET
Omega Healthcare Investors announced the planned CEO succession: President Matthew P. Gourmand was appointed President and CEO effective October 1, 2026, succeeding C. Taylor Pickett upon his retirement. Gourmand also joined the board. The retirement is stated as not resulting from any disagreement. This is a routine, pre-disclosed leadership transition with no financial or operational surprises.
- Matthew P. Gourmand appointed President and CEO effective October 1, 2026, succeeding retiring CEO C. Taylor Pickett.
- Gourmand also appointed to the board to fill Pickett's vacancy, term expiring 2027.
- Pickett's retirement is not due to any disagreement with the company.
- Board size remains at eight; Gourmand not expected to join any board committees.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access